Inventor · disambiguated record
Roger Paul Hollis
Also filed as: HOLLIS ROGER · HOLLIS ROGER P · HOLLIS ROGER PAUL
4 granted patents·12 pending applications·21 citations·filing 1999–2024
66Inventor score
Top patents by PatentIndex Score
16 records- 0174US12060566B2Self-inactivating lentiviral vector comprising a FOXP3 expression cassetteUNIV CALIFORNIA·Filed 2018·Granted Aug 13, 2024·1 cites·13 claims
- 0272US2024336935A1Self-inactivating lentiviral vector comprising a foxp3 expression cassetteUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0365US2025235480A1Vectors combining anti-sickling beta-as3-globin with anti bcel11a shrnamir to treat beta-hemoglobinopathiesUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0464US2025381295A1Lentiviral vectors expressing alpha-globin genes for gene therapy of alpha thalassemiaUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0558US2024200100A1Packaging cells with targeted gene knockouts that improve retroviral vector titersUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 0655US2024082427A1Method of designing highly regulated lentiviral vectors possesing strict endogenous regulationUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 0754US2022389454A1Lentiviral vectors in hematopoietic stem cells to treat recombination-activating gene 1 (rag1) severe combined immunodeficiency (scid)UNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 0852US2022378937A1Lentiviral vectors in hematopoietic stem cells to treat x-linked chronic granulomatous diseaseUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 0951US2022170045A1Augmentations to lentiviral vectors (cclc-mgata/ank-core lcr-beta-as3-fb) to increase expressionUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1050US2022136007A1Optimized lentiviral vector compromising minimal enhancer elements for stem cell gene therapy of hemoglobinopathiesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1149US2022387528A1Lentiviral vectors in hematopoietic stem cells to treat wiskott-aldrich syndrome (was)UNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1246US11976293B2Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathiesUNIV CALIFORNIA·Filed 2017·Granted May 7, 2024·0 cites·12 claims
- 1346US6406856B1BiosensorUNIV ABERDEEN·Filed 1999·Granted Jun 18, 2002·20 cites·29 claims
- 1446US2015224209A1Lentiviral vector for stem cell gene therapy of sickle cell diseaseKOHN DONALD B·Filed 2013·Application pending·0 cites
- 1546US2017157270A1Lentiviral vector for stem cell gene therapy of sickle cell diseaseUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 1645US12492411B2Gene editing of monogenic disorders in human hematopoietic stem cells—correction of X-linked agammaglobulinemia (XLA)UNIV CALIFORNIA·Filed 2019·Granted Dec 9, 2025·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Roger Paul Hollis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →